nobiletin has been researched along with Cognition Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, Y; Kim, HC; Mimaki, Y; Nagai, T; Nakai, T; Nakajima, A; Nguyen, TT; Ohizumi, Y; Shin, EJ; Yamada, K; Yamada, S; Yokosuka, A | 1 |
| Fukunaga, K; Mimaki, Y; Ohizumi, Y; Yabuki, Y; Yokosuka, A | 1 |
| Nakajima, A; Ohizumi, Y; Yamakuni, T | 1 |
1 review(s) available for nobiletin and Cognition Disorders
| Article | Year |
|---|---|
Pharmacological action of nobiletin, a component of AURANTII NOBILIS PERICARPIUM with anti-dementia activity, and its application for development of functional foods.
Topics: Alzheimer Disease; Animals; Cognition Disorders; Disease Models, Animal; Flavones; Foods, Specialized; Hippocampus; Humans; Learning Disabilities; Memory Disorders; Mice; Neurons; Plants, Medicinal; Rats; Signal Transduction | 2008 |
2 other study(ies) available for nobiletin and Cognition Disorders
| Article | Year |
|---|---|
Nobiletin, a citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-accelerated mouse.
Topics: Aging; Analysis of Variance; Animals; Antioxidants; Body Weight; Case-Control Studies; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Fear; Flavones; Glutathione; Glutathione Peroxidase; Lipid Metabolism; Male; Maze Learning; Mice; Mice, Transgenic; Oxidative Stress; Phosphorylation; Protein Carbonylation; Superoxide Dismutase; tau Proteins | 2013 |
Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Topics: Animals; Antioxidants; Avoidance Learning; Brain; Calcium Channel Blockers; Cognition Disorders; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Flavones; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Parkinsonian Disorders; Psychomotor Performance; Signal Transduction | 2014 |